25 May 2023 - Australians battling prostate cancer that has spread past the prostate will soon benefit from subsidised medicine ...
24 May 2023 - The Public Summary Document of the PBAC's consideration of the interim report of the post-market review of ...
24 May 2023 - Children born with the most common form of dwarfism will have access to a new life ...
24 May 2023 - The PBAC has recommended the listing of natalizumab (Tysabri) pre-filled syringe for subcutaneous injection on the PBS. ...
18 May 2023 - This study aimed to assess whether there have been changes in the quality of clinical evidence ...
15 May 2023 - The Royal Australian College of GPs (RACGP) has welcomed the PBAC's decision to remove limitations requiring ...
15 May 2023 - A long-time chair of the government’s independent pharmaceutical advisory body has rebuked the powerful pharmacy lobby ...
12 May 2023 - The chair of the PBAC has dismissed concerns that 60 day dispensing will cause medicine shortages, ...
12 May 2023 - Consultation on the draft 2023-24 Cost Recovery Implementation Statement (CRIS) for listing medicines on the Pharmaceutical ...
12 May 2023 - The independent, expert group advising the Australian Government on PBS medications has reviewed its recommendation to put ...
12 May 2023 - The outcome for fluticasone propionate from the May 2023 PBAC meeting is now available. ...
11 May 2023 - The Australian Government is making hundreds of medicines cheaper by allowing millions of Australians to buy two ...
11 May 2023 - Information regarding the experts in HTA to support the HTA Review is now available. ...
10 May 2023 - In the 2023-24 Budget, the Australian Government committed $377.3 million over 4 years from 2023–24 (and $98.4 ...
10 May 2023 - Recommendations made out-of-session by the PBAC between its March 2023 and July 2023 meetings are now available. ...